Skip to content
WatchlistMedium

CVE-2018-16133Cybrohttpserver Path Traversal

Cybrotech CyBroHttpServer 1.0.3 allows Directory Traversal via a ../ in the URI.

Published Aug 29, 2018 · Updated Nov 21, 2024

Key Facts

Routine patching
  • CVE-2018-16133 is a medium-severity vulnerability (CVSS 5.3 v3) affecting Cybrohttpserver (Cybrotech).
  • It is not listed in any known-exploited vulnerabilities catalog. Public exploit code is available.
  • EPSS estimates a 39% probability of exploitation in the next 30 days.
  • No fixed version is listed yet; check the vendor advisory for mitigations.
  • Brandefense priority: routine patching, as no exploitation is known and its severity is moderate or low.

Scores

CVSS v3

5.3

CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

EPSS (30-day exploit likelihood)

39%

Higher than 98.5% of all scored CVEs

Exploit maturity

Proof of concept

ATLAS score

38/100

Publication score, see How it works

Exploitation Verdict

KEV listed

Not listed

Federal due date

None

No federal due date

Ransomware use

Not reported

Attributed actors

None named

Exploit & Defence Guidance

Exploit maturity

Proof of concept

Public exploit code

3

Proof-of-concept links

In-the-wild evidence

1

Reports of active use

Description

Cybrotech CyBroHttpServer 1.0.3 allows Directory Traversal via a ../ in the URI.

Affected Products

1 affected entries in total
ProductAffected versionsFixed in
CybrohttpserverCybrotech1.0.3n/a

Timeline

  1. Publicly disclosed

    Aug 29, 2018

  2. Last updated

    Nov 21, 2024

Weakness Type

  • CWE-22 Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')

FAQ

Common Questions.

Is CVE-2018-16133 On Your Attack Surface?

Brandefense matches it against the products discovered on your perimeter and opens a finding the day a CVE like this is listed.

Request A Demo

Figures as of Oct 19, 2026. Compiled by Brandefense technologies from public vulnerability catalogs; scoring as described in How it works.

To report an error, contact Brandefense.